277 related articles for article (PubMed ID: 11377928)
1. Tyrosine augments acute clozapine- but not haloperidol-induced dopamine release in the medial prefrontal cortex of the rat: an in vivo microdialysis study.
Jaskiw GE; Collins KA; Pehek EA; Yamamoto BK
Neuropsychopharmacology; 2001 Jul; 25(1):149-56. PubMed ID: 11377928
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine augments clozapine-induced dopamine release in the medial prefrontal cortex of the rat in vivo: effects of access to food.
Jaskiw GE; Simpson C; Bongiovanni R; Yamamoto BK
Neurosci Lett; 2004 Feb; 357(1):5-8. PubMed ID: 15036600
[TBL] [Abstract][Full Text] [Related]
3. Clozapine-induced dopamine release in the medial prefrontal cortex is augmented by a moderate concentration of locally administered tyrosine but attenuated by high tyrosine concentrations or by tyrosine depletion.
Jaskiw GE; Kirkbride B; Newbould E; Young D; Durkalski V; Bongiovanni R
Psychopharmacology (Berl); 2005 Jun; 179(4):713-24. PubMed ID: 15682305
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M
Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763
[TBL] [Abstract][Full Text] [Related]
5. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
Bongiovanni R; Young D; Newbould E; Jaskiw GE
Brain Res; 2006 Oct; 1115(1):26-36. PubMed ID: 16934236
[TBL] [Abstract][Full Text] [Related]
6. Modulation of dopamine release by striatal 5-HT2C receptors.
Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
[TBL] [Abstract][Full Text] [Related]
7. Clozapine preferentially increases dopamine release in the rhesus monkey prefrontal cortex compared with the caudate nucleus.
Youngren KD; Inglis FM; Pivirotto PJ; Jedema HP; Bradberry CW; Goldman-Rakic PS; Roth RH; Moghaddam B
Neuropsychopharmacology; 1999 May; 20(5):403-12. PubMed ID: 10192821
[TBL] [Abstract][Full Text] [Related]
8. Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic.
Devoto P; Flore G; Vacca G; Pira L; Arca A; Casu MA; Pani L; Gessa GL
Psychopharmacology (Berl); 2003 Apr; 167(1):79-84. PubMed ID: 12632247
[TBL] [Abstract][Full Text] [Related]
9. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
[TBL] [Abstract][Full Text] [Related]
10. The effects of haloperidol and clozapine on extracellular GABA levels in the prefrontal cortex of the rat: an in vivo microdialysis study.
Bourdelais AJ; Deutch AY
Cereb Cortex; 1994; 4(1):69-77. PubMed ID: 8180492
[TBL] [Abstract][Full Text] [Related]
11. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
Broderick PA; Piercey MF
J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
[TBL] [Abstract][Full Text] [Related]
12. Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat.
López-Gil X; Babot Z; Amargós-Bosch M; Suñol C; Artigas F; Adell A
Neuropsychopharmacology; 2007 Oct; 32(10):2087-97. PubMed ID: 17356574
[TBL] [Abstract][Full Text] [Related]
13. In rats chronically treated with clozapine, tyrosine depletion attenuates the clozapine-induced in vivo increase in prefrontal cortex dopamine and norepinephrine levels.
Jaskiw GE; Kirkbride B; Bongiovanni R
Psychopharmacology (Berl); 2006 May; 185(4):416-22. PubMed ID: 16541248
[TBL] [Abstract][Full Text] [Related]
14. R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(-)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum.
Ichikawa J; Meltzer HY
J Pharmacol Exp Ther; 1999 Dec; 291(3):1227-32. PubMed ID: 10565846
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist.
Leggio GM; Cathala A; Neny M; Rouge-Pont F; Drago F; Piazza PV; Spampinato U
J Neurochem; 2009 Oct; 111(2):614-23. PubMed ID: 19702657
[TBL] [Abstract][Full Text] [Related]
16. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
Bruins Slot LA; Lestienne F; Grevoz-Barret C; Newman-Tancredi A; Cussac D
Eur J Pharmacol; 2009 Oct; 620(1-3):27-35. PubMed ID: 19695244
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortex.
Li Z; Prus AJ; Dai J; Meltzer HY
J Pharmacol Exp Ther; 2009 Sep; 330(3):948-55. PubMed ID: 19491322
[TBL] [Abstract][Full Text] [Related]
18. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.
Kuroki T; Meltzer HY; Ichikawa J
J Pharmacol Exp Ther; 1999 Feb; 288(2):774-81. PubMed ID: 9918588
[TBL] [Abstract][Full Text] [Related]
19. 5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner.
Liégeois JF; Ichikawa J; Meltzer HY
Brain Res; 2002 Aug; 947(2):157-65. PubMed ID: 12176156
[TBL] [Abstract][Full Text] [Related]
20. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
Ichikawa J; Li Z; Dai J; Meltzer HY
Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
